ORIGENERE TR1 is a patented multi phase plant extract for stopping hair loss and re growing hair to treat male pattern baldness in men and women. TR1 comes as a topical application in oil spray or foam.
TR1 was launched in October 2012. TR1 is only retailed through Alvi Armani Hair Transplant clinics in US, UK, and Canada. Other cosmetics were launched in 2008.
TR1 regrows hair all over the head versus Minoxidil and Finasteride that only maintain the existing hair in crown area (top) of the head. TR1 has no side effects compared to Minoxidil and Finasteride.
POC study for TR1 has shown hair re growth up to 38% average in a 3 month 20-patient study versus 10%-30% "hair maintenance" with the use of Minoxidil over a 8 month study. Full scientific study with micro images available.
Capital is being sought to mass market TR1 as a "cosmetic" and continue research to make TR1 a "drug" with plans to take up to FDA phase II and subsequently sell or license to large pharma.